Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patient-reported outcomes during first-line palliative systemic therapy alternated with pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases: a single-arm phase II trial (CRC-PIPAC-II).
van de Vlasakker VCJ, Rauwerdink P, Rovers KPB, Wassenaar EC, Creemers GJ, Los M, Burger JWA, Nienhuijs SW, Kranenburg O, Wiezer MJ, Lurvink RJ, Boerma D, de Hingh IHJT. van de Vlasakker VCJ, et al. Surg Endosc. 2024 Nov;38(11):6566-6576. doi: 10.1007/s00464-024-11185-z. Epub 2024 Sep 16. Surg Endosc. 2024. PMID: 39285036 Free PMC article. Clinical Trial.
First-line palliative systemic therapy alternated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases: A single-arm phase II trial (CRC-PIPAC-II).
Rauwerdink P, van de Vlasakker VCJ, Wassenaar ECE, Rovers KP, Los M, Herbschleb KH, Creemers GM, Thijs AMJ, Raicu MG, Huysentruyt CJR, van der Hoeven EJRJ, Nederend J, Peeters RYM, Deenen MJ, Elias SG, Fijneman RJA, Constantinides A, Kranenburg O, Burger PWA, Nienhuijs SW, Wiezer RJ, Lurvink RJ, de Hingh IHJT, Boerma D. Rauwerdink P, et al. Among authors: van de vlasakker vcj. Eur J Surg Oncol. 2024 Sep;50(9):108487. doi: 10.1016/j.ejso.2024.108487. Epub 2024 Jun 13. Eur J Surg Oncol. 2024. PMID: 38905732 Clinical Trial.
Exploiting a subtype-specific mitochondrial vulnerability for successful treatment of colorectal peritoneal metastases.
Bootsma S, Dings MPG, Kesselaar J, Helderman RFCPA, van Megesen K, Constantinides A, Moreno LF, Stelloo E, Scutigliani EM, Bokan B, Torang A, van Hooff SR, Zwijnenburg DA, Wouters VM, van de Vlasakker VCJ, Galanos LJK, Nijman LE, Logiantara A, Veenstra VL, Schlingemann S, van Piggelen S, van der Wel N, Krawczyk PM, Platteeuw JJ, Tuynman JB, de Hingh IH, Klomp JPG, Oubrie A, Snaebjornsson P, Medema JP, Oei AL, Kranenburg O, Elbers CC, Lenos KJ, Vermeulen L, Bijlsma MF. Bootsma S, et al. Among authors: van de vlasakker vcj. Cell Rep Med. 2024 May 21;5(5):101523. doi: 10.1016/j.xcrm.2024.101523. Epub 2024 Apr 25. Cell Rep Med. 2024. PMID: 38670098 Free PMC article.
Development of a prediction model for recurrence in patients with colorectal peritoneal metastases undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
Dietz MV, Hannink G, Said I, van der Zant FA, van de Vlasakker VCJ, Brandt-Kerkhof ARM, Verhoef C, Bremers AJA, de Wilt JHW, Hemmer PHJ, de Hingh IHJT, de Reuver PR, Madsen EVE. Dietz MV, et al. Among authors: van de vlasakker vcj. Eur J Surg Oncol. 2024 Jun;50(6):108294. doi: 10.1016/j.ejso.2024.108294. Epub 2024 Apr 4. Eur J Surg Oncol. 2024. PMID: 38583215 Free article.
Intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for patients with unresectable colorectal peritoneal metastases: protocol of the multicentre, open-label, phase II, INTERACT-II trial.
van de Vlasakker VCJ, Guchelaar NAD, van den Heuvel TBM, Lurvink RJ, van Meerten E, Bax RJF, Creemers GM, van Hellemond IEG, Brandt-Kerkhof ARM, Madsen EVE, Nederend J, Koolen SLW, Nienhuijs SW, Kranenburg O, de Hingh IHJT, Verhoef C, Mathijssen RHJ, Burger JWA; Dutch Peritoneal Oncology Group; Dutch Colorectal Cancer Group. van de Vlasakker VCJ, et al. BMJ Open. 2024 Jan 18;14(1):e077667. doi: 10.1136/bmjopen-2023-077667. BMJ Open. 2024. PMID: 38238055 Free PMC article.
Comparing patient reported abdominal pain between patients treated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC-OX) and primary colorectal cancer surgery.
van de Vlasakker VCJ, Lurvink RJ, Wassenaar EC, Rauwerdink P, Bakkers C, Rovers KP, Bonhof CS, Burger JWA, Wiezer MJ, Boerma D, Nienhuijs SW, Mols F, de Hingh IHJT. van de Vlasakker VCJ, et al. Sci Rep. 2023 Nov 22;13(1):20458. doi: 10.1038/s41598-023-47510-0. Sci Rep. 2023. PMID: 37993560 Free PMC article.
Primary tumor resection or systemic treatment as palliative treatment for patients with isolated synchronous colorectal cancer peritoneal metastases in a nationwide cohort study.
Rijken A, van de Vlasakker VCJ, Simkens GA, Rovers KP, van Erning FN, Koopman M, Verhoef C, de Wilt JHW, de Hingh IHJT. Rijken A, et al. Among authors: van de vlasakker vcj. Clin Exp Metastasis. 2023 Aug;40(4):289-298. doi: 10.1007/s10585-023-10212-y. Epub 2023 May 20. Clin Exp Metastasis. 2023. PMID: 37209222 Free PMC article.
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy with Intra-Operative Radiotherapy for Patients with Locally Advanced or Locally Recurrent Rectal Cancer and Peritoneal Metastases.
van de Vlasakker VCJ, van den Heuvel TBM, Rijken A, Nienhuijs SW, Ketelaers SHJ, Verrijssen AE, Rutten HJ, Nieuwenhuijzen GAP, Burger JWA, de Hingh IHJT. van de Vlasakker VCJ, et al. Cancers (Basel). 2023 Jan 30;15(3):858. doi: 10.3390/cancers15030858. Cancers (Basel). 2023. PMID: 36765814 Free PMC article.
The Impact of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) versus Conventional Surgery on Patient-Reported Outcomes: A Comparative Cohort Study between the CAIRO6 Trial and the PROCORE Study.
Bakkers C, van de Vlasakker VCJ, Rovers KPB, Lurvink RJ, Nienhuijs SW, Burger JWA, Creemers GM, Bonhof CS, Mols F, de Hingh IHJT. Bakkers C, et al. Among authors: van de vlasakker vcj. Cancers (Basel). 2023 Jan 27;15(3):788. doi: 10.3390/cancers15030788. Cancers (Basel). 2023. PMID: 36765746 Free PMC article.
13 results